glp 1 patent expiration date 8 key drug patents expiring soon — and what it means for the market Weight-loss drugs such as Ozempic
Description
10.2337/diabetes.53.3.654 163 MeierJ
1995 Mar
Tirzepatide causes thyroid C-cell tumors in rats, and although its unknown whether tirzepatide causes thyroid C-cell tumors in humans, it is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Potential Downsides of Microdosing Reduced Efficacy One of the primary concerns with microdosing GLP-1 drugs is that lower doses may not provide the desired therapeutic effects

The role of carbohydrate sensing in the gut on the long-term regulation of energy homeostasis is thus currently unclear

Competitive pricing and subscription refill services further encourage patient adoption
